Search
for
Sort by
Research 781–810 of 1000+
- Development and Validation of A C57BL/6 Mouse Model of Androgenetic Alopecia Through Testosterone Propionate Induction
- Autologous Platelet Concentrates in Periodontology : Science, Concept, Protocols and Clinical Applications
- Deucravacitinib in dermatology: current indication and existing off-label data
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Discoid lupus erythematosus successfully treated with deucravacitinib
- A Comprehensive Review of Acne Treatments: Unpacking the Chemical Structures and Effective Bioactive Compounds
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Baricitinib for the Treatment of Alopecia Areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- The inflammatory component of androgenetic alopecia
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Treatment of Alopecia Areata With Tofacitinib
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Upadacitinib for the treatment of alopecia areata – A case report
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience